OXLUMO® (lumasiran) | Official Patient Website
OXLUMO® (lumasiran) is the first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) by lowering oxalate in urine. See Important Safety Information on risk of injection site reactions.
Understanding primary hyperoxaluria type 1 (PH1) - OXLUMO® …
Learn about PH1. OXLUMO® (lumasiran) is the first FDA approved prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood. See Important Safety Information on risk of injection site reactions.
Starting OXLUMO® (lumasiran)
OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults. Prescribing Information. OXLUMO® (lumasiran) is given by a healthcare provider as an injection. Talk to your doctor to learn more.
OXLUMO works by reducing oxalate production - OXLUMO® …
OXLUMO® (lumasiran) is the first FDA‐approved prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood. See Important Safety Information on risk of injection site reactions.
OXLUMO® (lumasiran) | Patient Support
OXLUMO is a prescription medicine for the treatment of PH1 to lower oxalate in urine and blood in children and adults. OXLUMO targets the GO enzyme—a liver enzyme involved in making oxalate. OXLUMO reduces levels of the GO enzyme so that less oxalate is …
OXLUMO is a HAO1-directed small interfering ribonucleic acid (siRNA) indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients.
Alnylam Patient Education Liaisons | OXLUMO® (lumasiran)
Our Alnylam Patient Education Liaisons (Alnylam PELs) can provide patients and families with information about treatment with OXLUMO® (lumasiran) and the condition it treats.
OXLUMO® (lumasiran)
OXLUMO® (lumasiran)
Site Map | OXLUMO® (lumasiran)
OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults. For additional information about OXLUMO, please see full . View the OXLUMO® (lumasiran) site map page.
Sign Up for Updates | OXLUMO® (lumasiran)
OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults. For additional information about OXLUMO, please see full Prescribing Information .